Non-alcoholic fatty liver disease(NAFLD)ranges from simple steatosis to nonalcoholic steatohepatitis(NASH),leading to fibrosis and potentially cirrhosis,and it
AIM:To evaluate the effects of the proteasome inhibitor bortezomib(BZB)on E2Fs and related genes in hepatocellular carcinoma(HCC)cells.METHODS:The mRNA levels o
Chronic alcohol exposure can lead to alcoholic liver disease,including hepatitis,cirrhosis and hepatocellular carcinoma,and chronic inflammation can simultaneou